Xilio Therapeutics's total assets for Q1 2026 were $163.49M, an increase of 5.69% from the previous quarter. XLO total liabilities were $90.94M for the fiscal quarter, a -23.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.